vs
GE医疗（DHC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是Orthofix Medical Inc.的1.7倍（$379.6M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -5.6%，领先4.6%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-166.4M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DHC vs OFIX — 直观对比
营收规模更大
DHC
是对方的1.7倍
$219.9M
营收增速更快
OFIX
高出2.0%
-0.0%
净利率更高
OFIX
高出4.6%
-5.6%
自由现金流更多
OFIX
多$183.3M
$-166.4M
两年增速更快
OFIX
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $379.6M | $219.9M |
| 净利润 | $-21.2M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -12.6% | 0.2% |
| 净利率 | -5.6% | -1.0% |
| 营收同比 | -0.0% | 2.0% |
| 净利润同比 | 75.7% | 92.4% |
| 每股收益（稀释后） | $-0.09 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHCOFIX
| Q4 25 | $379.6M | $219.9M | ||
| Q3 25 | $388.7M | $205.6M | ||
| Q2 25 | $382.7M | $203.1M | ||
| Q1 25 | $386.9M | $193.6M | ||
| Q4 24 | $379.6M | $215.7M | ||
| Q3 24 | $373.6M | $196.6M | ||
| Q2 24 | $371.4M | $198.6M | ||
| Q1 24 | $370.8M | $188.6M |
净利润DHCOFIX
| Q4 25 | $-21.2M | $-2.2M | ||
| Q3 25 | $-164.0M | $-22.8M | ||
| Q2 25 | $-91.6M | $-14.1M | ||
| Q1 25 | $-9.0M | $-53.1M | ||
| Q4 24 | $-87.4M | $-29.1M | ||
| Q3 24 | $-98.7M | $-27.4M | ||
| Q2 24 | $-97.9M | $-33.4M | ||
| Q1 24 | $-86.3M | $-36.0M |
毛利率DHCOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率DHCOFIX
| Q4 25 | -12.6% | 0.2% | ||
| Q3 25 | -43.4% | -8.3% | ||
| Q2 25 | -24.5% | -7.9% | ||
| Q1 25 | -2.7% | -25.2% | ||
| Q4 24 | -26.1% | -5.3% | ||
| Q3 24 | -26.5% | -9.6% | ||
| Q2 24 | -23.0% | -12.5% | ||
| Q1 24 | -23.7% | -15.6% |
净利率DHCOFIX
| Q4 25 | -5.6% | -1.0% | ||
| Q3 25 | -42.2% | -11.1% | ||
| Q2 25 | -23.9% | -6.9% | ||
| Q1 25 | -2.3% | -27.4% | ||
| Q4 24 | -23.0% | -13.5% | ||
| Q3 24 | -26.4% | -13.9% | ||
| Q2 24 | -26.3% | -16.8% | ||
| Q1 24 | -23.3% | -19.1% |
每股收益（稀释后）DHCOFIX
| Q4 25 | $-0.09 | $-0.05 | ||
| Q3 25 | $-0.68 | $-0.57 | ||
| Q2 25 | $-0.38 | $-0.36 | ||
| Q1 25 | $-0.04 | $-1.35 | ||
| Q4 24 | $-0.37 | $-0.76 | ||
| Q3 24 | $-0.41 | $-0.71 | ||
| Q2 24 | $-0.41 | $-0.88 | ||
| Q1 24 | $-0.36 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $82.0M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.7B | $450.0M |
| 总资产 | $4.4B | $850.6M |
| 负债/权益比越低杠杆越低 | 1.47× | — |
8季度趋势，按日历期对齐
现金及短期投资DHCOFIX
| Q4 25 | $105.4M | $82.0M | ||
| Q3 25 | $201.4M | $62.9M | ||
| Q2 25 | $141.8M | $65.6M | ||
| Q1 25 | $302.6M | $58.0M | ||
| Q4 24 | $144.6M | $83.2M | ||
| Q3 24 | $256.5M | $30.1M | ||
| Q2 24 | $265.6M | $26.4M | ||
| Q1 24 | $207.1M | $27.0M |
总债务DHCOFIX
| Q4 25 | $2.4B | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $3.1B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益DHCOFIX
| Q4 25 | $1.7B | $450.0M | ||
| Q3 25 | $1.7B | $442.5M | ||
| Q2 25 | $1.9B | $458.3M | ||
| Q1 25 | $1.9B | $458.3M | ||
| Q4 24 | $2.0B | $503.1M | ||
| Q3 24 | $2.0B | $525.9M | ||
| Q2 24 | $2.1B | $546.0M | ||
| Q1 24 | $2.2B | $570.3M |
总资产DHCOFIX
| Q4 25 | $4.4B | $850.6M | ||
| Q3 25 | $4.7B | $832.6M | ||
| Q2 25 | $4.8B | $837.2M | ||
| Q1 25 | $5.0B | $823.1M | ||
| Q4 24 | $5.1B | $893.3M | ||
| Q3 24 | $5.3B | $867.9M | ||
| Q2 24 | $5.3B | $882.0M | ||
| Q1 24 | $5.3B | $906.0M |
负债/权益比DHCOFIX
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 1.56× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $16.8M |
| 自由现金流率自由现金流/营收 | -43.8% | 7.6% |
| 资本支出强度资本支出/营收 | 38.7% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-280.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DHCOFIX
| Q4 25 | $-19.6M | $27.7M | ||
| Q3 25 | $-49.3M | $12.4M | ||
| Q2 25 | $53.0M | $11.6M | ||
| Q1 25 | $-3.2M | $-18.4M | ||
| Q4 24 | $112.2M | $23.7M | ||
| Q3 24 | $21.1M | $11.7M | ||
| Q2 24 | $44.3M | $9.0M | ||
| Q1 24 | $28.6M | $-18.6M |
自由现金流DHCOFIX
| Q4 25 | $-166.4M | $16.8M | ||
| Q3 25 | $-89.8M | $2.5M | ||
| Q2 25 | $18.8M | $4.5M | ||
| Q1 25 | $-42.9M | $-25.1M | ||
| Q4 24 | $-89.5M | $15.2M | ||
| Q3 24 | $-26.1M | $6.3M | ||
| Q2 24 | $3.3M | $-360.0K | ||
| Q1 24 | $-18.1M | $-29.1M |
自由现金流率DHCOFIX
| Q4 25 | -43.8% | 7.6% | ||
| Q3 25 | -23.1% | 1.2% | ||
| Q2 25 | 4.9% | 2.2% | ||
| Q1 25 | -11.1% | -13.0% | ||
| Q4 24 | -23.6% | 7.0% | ||
| Q3 24 | -7.0% | 3.2% | ||
| Q2 24 | 0.9% | -0.2% | ||
| Q1 24 | -4.9% | -15.4% |
资本支出强度DHCOFIX
| Q4 25 | 38.7% | 4.9% | ||
| Q3 25 | 10.4% | 4.8% | ||
| Q2 25 | 8.9% | 3.5% | ||
| Q1 25 | 10.2% | 3.5% | ||
| Q4 24 | 53.1% | 4.0% | ||
| Q3 24 | 12.6% | 2.7% | ||
| Q2 24 | 11.0% | 4.7% | ||
| Q1 24 | 12.6% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
